Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 1,169 HALO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/Award | 1,169 | n/a |
| Jul 16, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 151 | $12.5K |
| Jun 18, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 454 | n/a |
| Jun 1, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 8,107 | n/a |
| May 27, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 2,851 | n/a |
| Apr 15, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 191 | $12.5K |
| Jan 20, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 197 | $12.5K |
| Nov 12, 2025 | ACADIA PHARMACEUTICALS INC (ACAD) | Sale | 30,000 | $671.0K |
| Aug 20, 2025 | CYTOKINETICS INC (CYTK) | Grant/Award | 27,450 | n/a |
| Jun 24, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 715 | n/a |